4 assets in Temporomandibular Joint Disorder

Therapeutic assets addressing Temporomandibular Joint Disorder, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Immunoglobulin G, Anti-(Human Calcitonin Gene-Related Peptide Receptor) (Human Monoclonal Heavy Chain), Disulfide With Human Monoclonal Light Chain, Dimer Temporomandibular Joint Disorder	University of Maryland, Baltimore	P2	CCC (53)
17-ALLYL-4,5A-EPOXY-3,14-DIHYDROXYMORPHINAN-6-ONE Temporomandibular Joint Disorder	University of Maryland, Baltimore	P1/2	CCC (48)
Capsaicin Temporomandibular Joint Disorder	Istanbul University	N/A	D (30)
Diclofenac Temporomandibular Joint Disorder	Istanbul University	N/A	D (30)